Procurement of CPD Courses
The Irish Institute of Pharmacy (IIOP) will commission a defined set of education and training programmes each year in line with national policy and evolving healthcare needs.
These programmes will be procured in line with the IIOP’s procurement policy and processes.
IIOP’s approach to the procurement process reflects not only good business practice in relation to the making of purchasing decisions but may also encompass national and EU rules and regulations.
The IIOP strives to ensure that all procurement activity is discharged honestly, fairly, and in a manner that secures best value for money. IIOP must be cost effective and efficient in the use of resources while upholding high standards of probity and integrity.
Training providers who wish to be included on the IIOP’s register of interested parties should contact firstname.lastname@example.org
Return to Training Providers .
The IIOP/RCSI awarded the following contracts:
|Training Programme||Training Provider||Date of contract|
Diagnosis and Treatment of an Acute Asthmatic Attack and the Supply and Administration of Salbutamol
|Hibernian Healthcare||23 September 2019|
|Mentoring skills for Pharmacists||Kingstown College||23 September 2019|
|Biological Medicines: Supporting your patients||Hibernian Healthcare||6 September 2019|
|Oral Anti-Cancer Medicines||Hibernian Healthcare||2 September 2019|
|Anticoagulation Training Programme||NI Centre for Pharmacy Learning and Development||1 July 2019|
|Cardiovascular Risk||NI Centre for Pharmacy Learning and Development||1 July 2019|
|Diabetes Training Programme||NI Centre for Pharmacy Learning and Development||1 July 2019|
|Diagnosis and Treatment of Hypoglycaemia and the Supply and Administration of Glucagon||NI Centre for Pharmacy Learning and Development||1 July 2019|
|Diagnosis and Treatment of a Severe Angina Attack and the Supply and Administration of Glyceryl Trinitrate||NI Centre for Pharmacy Learning and Development||1 July 2019|
|Managing Quality in Pharmacy Practice and Quality Improvement in the Supply of High Risk Medicines||Pharmapod||28 June 2019|